Skip to main content
Fig. 8 | Biology Direct

Fig. 8

From: Construction of a prognostic model based on disulfidptosis-related genes and identification of CCNA2 as a novel biomarker for hepatocellular carcinoma

Fig. 8

Clinical value of CCNA2. (A-B) Differential expression of CCNA2 in dysplastic liver tissue and HCC in GSE6764 and GSE89377. (C-D) Sensitivity of CCNA2 for differentiating dysplastic liver tissue and HCC in GSE6764 and GSE89377. (E-F) Differential survival of (E)OS and (F) DFS in high-expression and low-expression of CCNA2. (G-H) K-M survival curve of high-expression and low-expression of CCNA2 in GSE116174 and GSE54236. (I-L) Differential expression of CCNA2 in different clinical traits such as T stage, clinical stage, G stage, and M stage in TCGA-LIHC

Back to article page

Biology Direct

ISSN: 1745-6150

Contact us